21.10.2021 18:00

Patient Monitoring Devices Market to grow US$ 37,476.7 Mn by end of 2028, Says Coherent Market Insights


SEATTLE, Oct. 21, 2021 /PRNewswire/ -- Patient monitoring devices, also called medical monitors, are medical instruments that allow health care professionals to remotely monitor the vital signs of a patient, including pulse rate, blood pressure, skin temperature, and respiration, using small, wireless transmitter-receivers that are carried or worn by the patient. These transmitter-receivers are typically attached to a belt or other personal item that enables the caregiver to readily check a patient's vital signs. This enables the caregiver to quickly identify any irregularities in the patient's bodily functions, such as a falling temperature or persistent sweating. Some monitoring systems come with extra sensors that can detect when a patient moves, making it possible to instantly inform the medical professional that something isn't working according to normal. 

Coherent Market Insights

The global patient monitoring devices market is estimated to account for 37,476.7 Mn in terms of value by the end of 2028.

Request for Sample PDF @ https://www.coherentmarketinsights.com/insight/request-sample/3991

Market Drivers

1.  Increasing prevalence of chronic diseases is expected to drive growth of the global patient monitoring devices market during the forecast period.

Chronic diseases such as cancer, hypertension, cardiovascular diseases (CVD), and diabetes are on the rise. According to the World Health Organization (WHO), in 2018, around 9.6 million died due to cancer with over 300,000 new cases of cancer being diagnosed each year among children aged 0-19 years across the globe. According to the same source, around 17.9 million people die each year from cardiovascular disease worldwide. Patient monitoring devices such as wearable heart monitors, glucose monitors, skin patches, and Bluetooth-enabled scales aid clinicians keep track of patients' health constantly.

2.  Technological advancements in patient monitoring devices are expected to propel the global patient monitoring devices market growth over the forecast period

Patient monitoring systems have improved significantly over the years with the availability of IoT-enabled devices, shoes, belts, non-invasive devices, and wearable to monitor different organs of the human body. These devices are easy to wear and can provide real-time data and analysis of the human body, enabling clinicians to provide prompt healthcare service.

Market Opportunity

1.  Increasing demand for non-invasive or minimally invasive devices can present lucrative growth opportunities

Patients are more inclined towards non-invasive or minimally invasive devices as these devices provide painless recording of different parameters such as blood pressure, pulse oximeter, electrocardiogram, oxygen analyzer, and more. For instance, in July 2020, Mitocon Biomed launched a new pulse oximeter Oxysat with 18 months replacement warranty.

2.  Rising demand for patient monitoring devices in non-hospital settings can provide prominent business opportunities

There are various patient monitoring devices that can be used in non-hospital settings such as glucose monitor, pulse oximeter, and infrared temperature gun. As a result of this, the adoption of these devices has increased in home, commercial, and industrial settings as well.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/3991 

Market Trends

1.  Cardiac monitoring systems are witnessing high demand

According to the WHO, cardiovascular disease (CVD) is the major cause of death across the globe. As a result of this, the demand for cardiac monitoring systems has increased across hospitals and clinics. With rising cases of CVD combined with the launch of new products and proactive government initiatives, cardiac monitoring systems are expected to witness high demand over the forecast period. For instance, in January 2020, Medtronic received the U.S. Food and Drug Administration (FDA) clearance for Micra AV, the smallest pacemaker with atrioventricular synchrony.

2.  North America region is witnessing robust growth

Among regions, North America is expected to witness significant growth in the global patient monitoring devices market. This is owing to increasing incidence of chronic diseases such as cancer and CVD coupled with the presence of robust healthcare facilities in the region.

Competitive Section

Major companies involved in the global patient monitoring devices market are Abbott Laboratories, Baxter International Inc., Boston Scientific Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company, Johnson & Johnson, and Medtronic plc.

Major companies are focused on product launches, in order to gain a competitive edge in the market. For instance, in February 2021, RhythMedix launched RhythmStar, a wearable cardiac monitor with 4G cellular connectivity.

Buy This Premium Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/3991 

Didn't find what you were looking for? Here are some similar topics:

Remote Patient Monitoring Devices Market, by Product Type (Cardiac Monitors, Respiratory Monitors, Hematological Monitors, and Others), by Application (Cardiac Arrhythmia, Diabetes, Ischemic Disease, Hypertension, Sleep Apnea, Chronic Respiratory Diseases, and Hyperlipidemia), by End User (Hospitals, Home Care Settings, Long-term Care Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Central Patient Monitoring Systems Market, By Number of Patients (16 Patients, 32 Patients, 64 Patients, 66 Patients, and >250 Patients), By End Users (Hospitals, Ambulatory Surgical Centers, Trauma Centers, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Multi-Parameter Patient Monitoring Equipment Market, by Equipment Type (High-acuity Monitors, Mid-acuity Monitors, and Low-acuity Monitors), by Application (Cardiology, Neurology, Respiratory, Fetal & Neonatal, and Others), by End User (Hospital, Clinics, Ambulatory Care Centers, and Home Healthcare), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Contact Us:

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com 
Website: https://www.coherentmarketinsights.com 
Follow Us: LinkedInTwitter

Logo : https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

Börse Stuttgart Anlegerclub

Heute im Fokus

Neue Virussorgen: DAX geht tiefrot ins Wochenende -- Ausverkauf in den USA -- Lufthansa fliegt vorerst weiter nach Südafrika -- Tesla verzichtet auf staatliche Förderung -- Software AG, K+S im Fokus

Apple macht iPhone in der Türkei über Nacht mehr als 25 Prozent teurer. Ocugen-Aktie: FDA stoppt Covaxin-Impfstoff. BioNTech prüft Wirksamkeit seines Impfstoffs gegen neue Corona-Variante. Nextcloud legt Beschwerde gegen Microsoft beim Bundeskartellamt ein. Kryptowährungen geben wegen neuer Virusvariante kräftig nach. Deutsche Bank: Entscheidend ob Impfstoffe gegen Variante wirken.


Sind Sie in Kryptowährungen wie Bitcoin, Ether & Co. investiert?

finanzen.net zero
finanzen.net zero



Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln